Verification evidence is still being completed.
PDF / print export
T-Knife
Berlin, Germany
- Verified lead
- Gabriele Eisner
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development
- Review cycle
- May 2026
- Full address
- Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official T-Knife contact page confirming the Berlin address.
- Editorial note
- T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development
Official leadership disclosure, Official Berlin address disclosure, Cell-therapy platform claim
T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated07 Jul 2026, 01:10
Company profile · Berlin, Germany
T-Knife
TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development · Clinical-stage cell-therapy platform
Verified 22 Mar 2026 · 3 sources
Cell TherapyClinical
T-Knife runs tcr-t development, cell-therapy programs, and oncology platform development in Berlin, Germany.
Contact & location
- Website
- t-knife.com
- Company page
- Lead
- Gabriele Eisner (verified ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (4mo ago)
- Scale
- Clinical-stage cell-therapy platform
- Capabilities
- TCR-T Development · Cell-Therapy Programs · Oncology Platform Development
- Founded
- 2018
- Headcount
- 51-200
TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development
T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
Editorial note
T-Knife is published because official company materials confirm current leadership, Berlin operating address, and a real TCR-T oncology platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Verification details
Clinical profileSTATUS: VERIFIED MARCH 2026
Gabriele Eisner
Chief Executive Officer
Full addressMax-Dohrn-Strasse 8-10, 10589 Berlin, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Clinical-stage cell-therapy platform
Berlin, Germany. TCR-T Cell Therapy, Oncology, Cell Therapy, Solid Tumors, and Clinical Development. Review completed on 22 Mar 2026.
German corporate and advanced-therapy oversight
Official leadership disclosure, Official Berlin address disclosure, Cell-therapy platform claim
Capabilities
TCR-T Development
Cell-Therapy Programs
Oncology Platform Development
Sources
The official sources used to verify this profile.
Infrastructure
T-cell engineering workflow
Cell-therapy program systems
Oncology R&D infrastructure
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
Frequently asked questions
- Where is T-Knife located?
- T-Knife operates from Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany, Berlin, Germany.
- Who runs T-Knife?
- T-Knife is led by Gabriele Eisner, Chief Executive Officer. Verified 22 Mar 2026.
- What does T-Knife do?
- T-Knife runs tcr-t development, cell-therapy programs, and oncology platform development in Berlin, Germany. Core capabilities: TCR-T Development, Cell-Therapy Programs, Oncology Platform Development.
Editorial context
Related technical briefs
Briefs that name Berlin as a covered market or city.